Role signal
Scientist III - Group Lead is the largest role bucket in the imported PERM rows shown here, with 1 matching rows.
PERM activity
Asklepios Biopharmaceutical PERM filings
PERM rows show part of the employment-based green-card process. They are useful for employer research, but they do not mean a green card was approved.
Imported PERM rows
1
Top PERM role
Scientist III - Group Lead
1 imported PERM rows
Source period
FY2026 Q3
PERM query context
How to read Asklepios Biopharmaceutical PERM employer results
For searches like "Asklepios Biopharmaceutical PERM", "Asklepios Biopharmaceutical green card sponsor", or "PERM employer", compare role, worksite, and status signals before opening individual rows.
Worksite signal
Research Triangle Park, NC is the largest worksite cluster in these PERM rows, with 1 matching rows.
See other H-1B sponsors in North Carolina.
Status signal
Certified is the largest case-status bucket in these PERM rows, with 1 rows.
Status lookup
PERM status signals for Asklepios Biopharmaceutical
For a PERM search by company, use the displayed status mix, latest imported decision, and source period as employer-level filing clues. They are not a case-specific PERM timeline or green-card approval forecast.
Latest PERM decision
Mar 18, 2026
From displayed Asklepios Biopharmaceutical PERM rows
Dominant status
Certified
1 displayed rows
Status share
100%
1 of 1 displayed rows
A PERM status check by employer works best when you compare this status mix with the row-level case table, the source period, and the general DOL FLAG PERM processing-time context. Those FLAG figures start at the ETA-9089: a prevailing wage determination (Form ETA-9141) is a separate National Prevailing Wage Center queue that closes before recruitment and before the PERM is filed, so the two waits stack rather than overlap — see prevailing wage processing times for that earlier queue. Rows can reflect different job titles, worksites, filing dates, and case outcomes, so the employer view is a research signal rather than a prediction for any worker or petition.
Filing mix
Asklepios Biopharmaceutical PERM vs H-1B/LCA activity
For "Asklepios Biopharmaceutical green card sponsor" research, compare the PERM labor-certification rows with the employer's H-1B/LCA filing base. They are separate DOL programs, so the mix is filing context rather than an approval rate.
PERM rows
1
H-1B/LCA rows
0
PERM per 100 LCA
n/a
Needs imported LCA rows
PERM-to-LCA filing mix: as of the latest verified DOL source trail on , VisaSignal shows 1 imported PERM rows and 0 imported H-1B/LCA rows for Asklepios Biopharmaceutical. Read the ratio as employer filing mix, not as a promise of sponsorship, hiring, certification, or green-card approval.
| Case | Status | Decision | Role | Worksite | Wage (per DOL pay unit) | Source |
|---|---|---|---|---|---|---|
| G-100-24310-455105 | Certified | Mar 18, 2026 | Scientist III - Group Lead | Research Triangle Park, NC | $109,600/ Year | FY2026 Q3 |
Primary source
Where this PERM filing signal comes from
PERM rows for Asklepios Biopharmaceutical are imported from DOL OFLC PERM Disclosure Data, the official US Department of Labor disclosure dataset. The PERM-to-LCA filing mix also references DOL OFLC LCA Disclosure Data for H-1B/LCA count context. See About data for caveats, DOL source status for when these disclosure files were last imported, and PERM processing times for general timing context. To compare this green-card signal with H-1B sponsorship history, run the employer through the H-1B sponsor checker or use the LCA and PERM database lookup to search PERM records across employers, roles, SOC codes, cities, and states.
DOL OFLC performance pageLast verified: . Page updated: .
Related sponsors
Sponsors adjacent to Asklepios Biopharmaceutical
Employers with imported DOL LCA or PERM filings that also list North Carolina worksites, weighted toward overlapping roles. Shared filing footprints are a research and discovery signal, not a hiring or sponsorship guarantee.
FAQ
Common questions
Does Asklepios Biopharmaceutical sponsor green cards?
Yes — Asklepios Biopharmaceutical has a documented PERM filing history: official US Department of Labor disclosure data lists 1 PERM permanent labor certification (green-card) record for this employer. The most recent imported disclosure period is FY2026 Q3. PERM is the first step of the employment-based green-card process, in which DOL certifies that no able and willing US worker was available for the position — so these rows are documented permanent-sponsorship activity, not a promise that Asklepios Biopharmaceutical will file for a new hire. Read the ratio as a comparison of disclosed filing volumes, not a green-card conversion rate: LCA and PERM are separate programs published on separate disclosure calendars, one PERM case covers a position rather than a named worker, and an employer can file PERM for workers who never held an H-1B. Verified against official DOL OFLC PERM disclosure data on 2026-08-09.
What does the Asklepios Biopharmaceutical PERM page show?
The Asklepios Biopharmaceutical PERM page summarizes imported DOL permanent labor certification rows for this normalized employer, including roles, worksites, wage signals, case-status mix, and source periods.
Does Asklepios Biopharmaceutical PERM activity guarantee a green card?
No. Official DOL disclosure data lists 1 PERM record for Asklepios Biopharmaceutical, but a certified PERM is only the labor-market test that opens an employment-based green-card case: it does not mean an I-140 petition, an adjustment of status, or a green card was approved for anyone. Verified against official DOL OFLC PERM disclosure data on 2026-08-09.
Can I use this for a Asklepios Biopharmaceutical PERM search by company?
Yes. Use the Asklepios Biopharmaceutical PERM page as a company-level lookup for imported DOL PERM disclosure rows, including job titles, worksites, case statuses, latest displayed decision dates, and source periods. For broader searches such as "PERM database" or "PERM records", use the LCA and PERM database lookup to search across employers.
How should I read Asklepios Biopharmaceutical PERM status or green-card processing?
A PERM status check by employer is a filing-history signal, not a timeline promise. Compare the dominant status bucket with the row-level table and the general DOL FLAG PERM processing-time context before drawing conclusions about Asklepios Biopharmaceutical green-card processing.
How should I compare Asklepios Biopharmaceutical PERM and H-1B/LCA filing activity?
Official DOL disclosure data lists 1 PERM record and 0 H-1B/LCA records for Asklepios Biopharmaceutical, so there is no PERM-to-LCA filing mix to read for this employer yet. The two programs are published on separate DOL disclosure calendars, so an absent ratio is a gap in the imported source periods rather than evidence about sponsorship, hiring, certification, or green-card approval. Verified against official DOL OFLC PERM disclosure data on 2026-08-09.
Does an LCA certification mean an H-1B petition was approved?
No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.
Does a PERM certification mean a green card was approved?
No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.
Can this data prove an employer will sponsor a candidate?
No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.
LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.